Last reviewed · How we verify
NCT05025202
Blood Pressure and Cardiac Autonomic Adaptations to Isometric Exercise Training
NA trial testing Isometric exercise training in Hypertension in 30 participants. Completed in 11 September 2020.
29 December 2019
Quick facts
| Lead sponsor | Canterbury Christ Church University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 15 January 2019 |
| Primary completion | 29 December 2019 |
| Estimated completion | 11 September 2020 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Isometric exercise training
Conditions studied
- Hypertension — all drugs for Hypertension →
Sponsor
Canterbury Christ Church University
Who can join
18 and older, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized, sham-controlled intervention measuring the effects of isometric exercise training (IET) on blood pressure and cardiac autonomics. IET has been proven effective in a plethora of randomized trials, but very little research has employed a sham-controlled design. This researched involved the recruitment of 30 participants who completed a 4 week IET intervention, sham control of the IET intervention, or a non-intervention control period. Pre and post blood pressure and cardiac autonomic measures were acquired and analysed. The hypothesis of this trial was a significant effect of IET on blood pressure, with no such effects following the sham control or normal control interventions.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Blood pressure and cardiac autonomic adaptations to isometric exercise training: A randomized sham-controlled study.
Decaux A, Edwards JJ, Swift HT, Hurst P, et al · · 2022 · cited 5× · PMID 35083878 · DOI 10.14814/phy2.15112
Verify or expand the search:
- PubMed search for NCT05025202
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other Canterbury Christ Church University trials
Trials by the same sponsor.
- NCT06402461 — Comparing Random Allocation and Allocation by Preference to Mindfulness Practice · NA · completed
- NCT07051005 — Feasibility of a Tailored Online Self-compassion Intervention · NA · recruiting
- NCT06821841 — Online Physical Activity Intervention for Peri- and Post-menopausal Working Women · NA · completed
- NCT06835777 — Neurophysiological Mechanisms of Placebo and Nocebo Effects in Sports - a Protocol Paper · NA · not yet recruiting
- NCT05749029 — An Online, Compassion Intervention for Adults with Type 1 and Type 2 Diabetes Mellitus (T1DM; T2DM). · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05025202 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Canterbury Christ Church University
- Last refreshed: 5 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05025202.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing